Product Description

CRAVEXIT Tablets contain Acamprosate Calcium 333 mg, an oral medication used as part of the management of alcohol dependence to support maintenance of abstinence following alcohol withdrawal.

The tablets are gastro-resistant and are supplied in a 10 × 6 Alu-Alu pack containing 60 tablets.

Therapeutic Uses

Acamprosate is used as part of a comprehensive treatment approach for alcohol dependence, particularly to help maintain abstinence after alcohol withdrawal.

It is generally used alongside appropriate psychosocial support and alcohol-dependence management rather than as a standalone treatment.